AzTrials
AzTrials

Brain Injury Traumatic MildNCT03478059

Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI

A study testing Cognitive and Motor Dual-task Intervention in people with Brain Injury Traumatic Mild and Concussion, Brain, run by Allina Health System at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research aims to develop an intervention that combines mTBI-specific motor and cognitive challenges into a progressive and challenging rehabilitation program. We plan to develop and refine a combined motor and cognitive intervention using healthy athletic young adults (n=12) and people with a positive history of… Read more about this study

Who is it for?
Ages 18 to 50 yearsHealthy volunteers can take part
What is being tested?
Cognitive and Motor Dual-task Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteUnited States
Study dates
31 Oct 2017to 30 Jun 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Adults aged 18-34 years of age.
  • Strong history of athletic participation including high school and collegiate varsity and/or club sports
  • Current sport or recreational sport participation at least 3 days per week
  • Willingness to participate in 3 times a week 60 minute exercise program conducted at Courage Kenny Research Center (CKRC).
  • Adults aged 18-50 years of age.
  • Self-report of some consistent exercise or activity a minimum of 2-3 days per week.
  • 3 weeks to 24 months post most recent concussion seeking treatment at Courage Kenny Rehabilitation Institute (CKRI) clinics
  • Willingness to participate in 3 times a week 60 minute exercise program conducted at CKRC.

Who cannot join

  • History of concussion.
  • History of orthopedic or neurologic diagnosis (stroke, multiple sclerosis, Parkinson's Disease, etc.) interfering with subject's ability to exercise
  • Unwilling to exercise.
  • At risk for cardiopulmonary disease as defined by the American College of Sports Medicine.
  • Active medical contraindications by self-report after explanation of dual-task exercise program.
  • Active chemical dependency or major psychiatric disorders (ie., schizophrenia, major psychosis) by self-report.
Show all 11Show fewer
  • History of orthopedic or neurologic diagnosis (stroke, multiple sclerosis, Parkinson Disease, etc.) interfering with subject's ability to exercise
  • Unwilling to exercise.
  • At risk for cardiopulmonary disease as defined by the American College of Sports Medicine.
  • Active medical contraindications by self-report after explanation of dual-task exercise program,
  • Active chemical dependency or major psychiatric disorders (ie., schizophrenia, major psychosis).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Abbott Northwestern Hospital

    Minneapolis, Minnesota, 55407

Other trials in United States

About this study

Official title: Exploring the Role of Combined Cognitive and Motor Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI

This research aims to develop an intervention that combines mTBI-specific motor and cognitive challenges into a progressive and challenging rehabilitation program. We plan to develop and refine a combined motor and cognitive intervention using healthy athletic young adults (n=12) and people with a positive history of non-resolving mTBI (n=12). We will conduct limited feasibility testing by conducting 6 week training sessions with each subject group. We also plan to identify best measures for determining readiness for duty or full function by incorporating and testing 3 dual-task assessment measures using state-of-the-art wearable sensors to quantify movement.

Being tested
Cognitive and Motor Dual-task Intervention
Medical subject headings
Brain Concussion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive and Motor Dual-task InterventionBehavioural

    The intervention will take place 3 times per week for 6 weeks (60 minutes/session) and employs motor and cognitive challenges. It is based on known motor and cognitive deficits after mTBI and is structured using a theoretical framework published in another domain of neurologic disease. The intervention will consist of 6 stations that target known motor and cognitive impairments after mTBI. Each station will have 3 levels of difficulty with optional cognitive progressions. Subjects will spend 8 minutes at each station with a 2 minute transition/rest period between stations and will be progressed in motor and cognitive difficulty as able.

Study groups in NCT03478059
Study groupRoleWhat they receive
Mild Traumatic Brain InjuryExperimental60 minute, 3 times per week, 6 week long Cognitive and Motor Dual-task Intervention program. The intervention will consist of 6 stations that target known motor and cognitive impairments after mTBI. Subjects with mTBI residuals will be gently progressed through exercise stations in an individually tailored fashion.
Receives: Behavioral: Cognitive and Motor Dual-task Intervention
Healthy ControlOther60 minute, 3 times per week, 6 week long Cognitive and Motor Dual-task Intervention program. The intervention will consist of 6 stations that target known motor and cognitive impairments after mTBI. In addition to providing comparison data, the healthy control, athletic 18-34 year old subjects will be used to identify levels and intensity of progressions of dual-task training stations appropriate for highly trained athletes and military personnel recovering from concussion.
Receives: Behavioral: Cognitive and Motor Dual-task Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in peak velocity turns during Instrumented Stand and Walk Test

    Change in peak velocity during 180 degree turns during Instrumented Stand and Walk Test in single task (ST) and dual-task (DT) conditions. DT condition involves grid memorization task.

    Measured: At baseline and after 6 weeks of intervention

Secondary outcomes (13)
  1. Change in peak turning velocity during walking a custom turning course

    Change in peak turning velocity during walking a custom turning course in ST and DT conditions.

    Measured: At baseline and after 6 weeks of intervention

  2. Change in peak turning velocity during running an agility course

    Change in peak turning velocity during running an agility course in ST and DT conditions.

    Measured: At baseline and after 6 weeks of intervention

  3. Change in medial -lateral (coronal plane) sway area during eyes closed, narrowed stance

    Change in medial -lateral (coronal plane) sway area during eyes closed, narrowed stance in ST and DT conditions.

    Measured: At baseline and after 6 weeks of intervention

  4. Change in Beck Depression Inventory-II

    Change in Beck Depression Inventory-II: 21 item self-administered questionnaire that measures intensity of depression.

    Measured: At baseline and after 6 weeks of intervention

  5. Change in Beck Anxiety Inventory

    Change in Beck Anxiety Inventory: 21 item self-administered questionnaire measuring subjective, somatic, or panic-related symptoms of anxiety.

    Measured: At baseline and after 6 weeks of intervention

  6. Change in Patient-specific Functional Scale

    Change in Patient-specific Functional Scale -quantifies the amount of functional limitation secondary to symptoms in up to 3 activities that are relevant to the individual patient. 0 to 10 scale, where 0 = unable to perform activity and 10 = able to perform activity at same level as before injury or problem.

    Measured: At baseline and after 6 weeks of intervention

  7. Change in Neurobehavioral Symptom Inventory (NSI)

    Change in Neurobehavioral Symptom Inventory (NSI): Self-report of residual symptoms "in last 2 weeks", a measure of post-TBI symptom severity, 0-4 scale on 22 symptom questions.

    Measured: At baseline and after 6 weeks of intervention

  8. Rey Auditory Verbal Learning Test Score

    Rey Auditory Verbal Learning Test which measures verbal learning and memory (short-term)

    Measured: At baseline

  9. Comprehensive Trails Making Test Score

    Comprehensive Trails Making Test which measures set shifting, attention, psychomotor speed

    Measured: Baseline

  10. Verbal Fluency Test Score

    Verbal Fluency which tests verbal ability and executive control

    Measured: Baseline

  11. NAB Digits Forward/Digits Backward Test Score

    NAB Digits Forward/Digits Backward Test which measures attentional capacity and auditory working memory

    Measured: Baseline

  12. Stroop Color-Word Test Score

    Stroop Color-Word Test to evaluate sustained and selective attention as well as freedom from distractibility and inhibitory control.

    Measured: Baseline

  13. Wide Range Achievement Test-4 Reading Score

    Wide Range Achievement Test-4 Reading will be used as an estimate of premorbid intellect

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Mar 2018
  2. Study start31 Oct 2017
  3. Primary completion30 Jun 2019
  4. Study completion30 Jun 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03478059
Sponsor's protocol ID
CKMW-1701
Status last verified
Aug 2019
First submitted
20 Mar 2018
Last updated
30 Aug 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive and Motor Dual-task Intervention in people with Brain Injury Traumatic Mild and Concussion, Brain, run by Allina Health System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 30 Aug 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in peak velocity turns during Instrumented Stand and Walk Test (time frame: At baseline and after 6 weeks of intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in